Legal / IP

AstraZenecaBoehringer Ingelheim

Merck Loses Third Circuit Appeal as Court Upholds Medicare Drug Price Negotiations Under IRA

The U.S. Court of Appeals for the Third Circuit ruled against Merck & Co., Inc. (MSD; NYSE: MRK), rejecting the drugmaker's claim that Medicare drug price negotiations violate the First…

WuXi AppTec Wins Preliminary Injunction Against DoD 1260H Designation

WuXi AppTec Wins Preliminary Injunction Against DoD 1260H Designation

Novo Nordisk Sues Eli Lilly Over Alleged False Advertising of Zepbound and Mounjaro in GLP-1 Market

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
HIV / AIDS careJ&J

Janssen Sues Distributors Over Counterfeit Antiretroviral Therapies in the US

AmgenHorizon Therapeutics

Amgen and Horizon Therapeutics Reach Agreement with FTC to Proceed with Acquisition

AstraZenecaAZ

Scott-Moncrieff & Associates Preparing 50 Cases Against AstraZeneca Over Vaccine Concerns

NYSE: PFEPfizer

Pfizer Faces Whistleblower Lawsuit Over Alleged FCPA Violations in China

Show More